News
In the demanding environment of laboratory work, burnout is a common issue. Explore how cutting-edge lab solutions can ...
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- ...
ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market Hong Kong-based venture capital firm ORI Capital plans to launch a new fund to ...
In an amazingly short time, China has developed globally leading technology and manufacturing in multiple sectors, including ...
The LSPN Europe 2025 Survey, which comes ahead of LSPN Europe in London in November, invites patent practitioners ...
Singh had instructed the complainant to hand over the bribe amount to his associate, Karsan Ganesh Ahir. Ahir was caught ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...
Scientists have identified a class of small antibodies that provide strong protection against a broad range of SARS-related ...
Shenzhen Zhongge Biotechnology Co. Ltd. has described proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase binding agent coupled to interleukin-1 receptor-associated ...
"Lymphopenia has long been recognized as a major driver and predictor of early mortality in cancer—yet until now, it has ...
Unlike Trump’s first term, the pharmaceutical industry is in far more peril than it has ever been in, and the biotech industry needs to ask itself an important question: Where does it fit in ...
Ph.D., MBA, Chief Executive Officer, Vir Biotechnology. "We successfully dosed the first patient in our ECLIPSE Phase 3 registrational program for hepatitis delta, a devastating disease with no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results